Very early onset inflammatory bowel disease.

Very early onset inflammatory bowel disease (VEO-IBD) represents a unique and growing subset of patients with inflammatory bowel disease (IBD). Some VEO-IBD patients present with immunodeficiency and possess loss of function genetic mutations involving immune pathways that cause their IBD. A search for Mendelian causes of IBD is likely most beneficial when the presentation involves extra-intestinal autoimmunity or involves intestinal histopathology that is atypical for IBD. While a subset of these young patients will have highly aggressive courses (and likely present with immunodeficiency), the majority of patients with VEO-IBD appear to have disease courses similar to that of their older counterparts. Most notably, many of these young children will require long courses of immunosuppression simply as a result of the profoundly early presentation-thus increasing their long-term risks of cancer and opportunistic infections.

[1]  Judy H. Cho,et al.  Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. , 2017, Gastroenterology.

[2]  I. Ordás,et al.  Long-lasting Remission Induced by Syngeneic Haematopoietic Stem Cell Transplantation in a Patient with Refractory Crohn's Disease. , 2016, Journal of Crohn's & colitis.

[3]  C. Klein,et al.  Large B-Cell Lymphoma in an Adolescent Patient With Interleukin-10 Receptor Deficiency and History of Infantile Inflammatory Bowel Disease. , 2016, Journal of pediatric gastroenterology and nutrition.

[4]  Eric E Schadt,et al.  Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease. , 2016, Gastroenterology.

[5]  I. Ordás,et al.  Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease , 2015, Gut.

[6]  Noor B. Dawany,et al.  A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report , 2015, BMC Gastroenterology.

[7]  H. Johnsen,et al.  Inherited Inflammatory Response Genes Are Associated with B-Cell Non-Hodgkin’s Lymphoma Risk and Survival , 2015, PloS one.

[8]  Judy H. Cho,et al.  Defects in Nicotinamide-adenine Dinucleotide Phosphate Oxidase Genes NOX1 and DUOX2 in Very Early Onset Inflammatory Bowel Disease , 2015, Cellular and molecular gastroenterology and hepatology.

[9]  David T. Okou,et al.  Dissecting Allele Architecture of Early Onset IBD Using High-Density Genotyping , 2015, PloS one.

[10]  S. Holland,et al.  Treatment With Anakinra, a Recombinant IL-1 Receptor Antagonist, Unlikely to Induce Lasting Remission in Patients With CGD Colitis , 2015, The American Journal of Gastroenterology.

[11]  Elisha D O Roberson,et al.  Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. , 2015, Blood.

[12]  J. Kelsen,et al.  Infliximab Therapy in Pediatric Patients 7 Years of Age and Younger , 2014, Journal of pediatric gastroenterology and nutrition.

[13]  A. Schäffer,et al.  Autosomal-dominant immune dysregulation syndrome in humans with CTLA4 mutations , 2014, Nature Medicine.

[14]  S. Snapper,et al.  Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. , 2014, Gastroenterology.

[15]  J. B. Oliveira,et al.  Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4 , 2014, Science.

[16]  J. Kere,et al.  Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease , 2014, Nature Genetics.

[17]  E. Schadt,et al.  Mutations in tetratricopeptide repeat domain 7A result in a severe form of very early onset inflammatory bowel disease. , 2014, Gastroenterology.

[18]  E. Miele,et al.  Phenotype and Disease Course of Early-onset Pediatric Inflammatory Bowel Disease , 2014, Inflammatory bowel diseases.

[19]  P. Rosenstiel,et al.  XIAP variants in male Crohn's disease , 2014, Gut.

[20]  R. Xavier,et al.  IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans , 2014, Proceedings of the National Academy of Sciences.

[21]  F. Rieux-Laucat,et al.  Phenotypic Characterization of Very Early-onset IBD Due to Mutations in the IL10, IL10 Receptor Alpha or Beta Gene: A Survey of the GENIUS Working Group , 2013, Inflammatory bowel diseases.

[22]  Yusun Jung,et al.  Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations , 2013, Gut.

[23]  M. Silverberg,et al.  IL-10R Polymorphisms Are Associated with Very-early-onset Ulcerative Colitis , 2013, Inflammatory bowel diseases.

[24]  A. Catto-Smith,et al.  Sixty-year Study of Incidence of Childhood Ulcerative Colitis Finds Eleven-fold Increase Beginning in 1990s , 2013, Inflammatory bowel diseases.

[25]  David C. Wilson,et al.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.

[26]  Michael D. Kappelman,et al.  Recent Trends in the Prevalence of Crohn’s Disease and Ulcerative Colitis in a Commercially Insured US Population , 2012, Digestive Diseases and Sciences.

[27]  J. Puchalka,et al.  Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. , 2012, Gastroenterology.

[28]  Tadashi Kaname,et al.  New from NPG , 2012, Nature Medicine.

[29]  Antonio J. Berlanga-Taylor,et al.  Rare variants in the CYP27B1 gene are associated with multiple sclerosis , 2011, Annals of neurology.

[30]  J. Shendure,et al.  Exome sequencing as a tool for Mendelian disease gene discovery , 2011, Nature Reviews Genetics.

[31]  R. Xavier,et al.  Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.

[32]  S. Holland,et al.  Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. , 2011, The Journal of allergy and clinical immunology.

[33]  F. Rieux-Laucat,et al.  Defective IL10 Signaling Defining a Subgroup of Patients With Inflammatory Bowel Disease , 2011, The American Journal of Gastroenterology.

[34]  David P Bick,et al.  Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease , 2011, Genetics in Medicine.

[35]  J. Orange,et al.  Complications of tumor necrosis factor-α blockade in chronic granulomatous disease-related colitis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  Jonathan C. Cohen,et al.  Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia. , 2010, The New England journal of medicine.

[37]  N. Sebire,et al.  Infant colitis—it's in the genes , 2010, The Lancet.

[38]  L. Mayer,et al.  Gastrointestinal manifestations in primary immune disorders. , 2010, Inflammatory bowel diseases.

[39]  P. Shannon,et al.  Exome sequencing identifies the cause of a Mendelian disorder , 2009, Nature Genetics.

[40]  H. Uhlig,et al.  Frequency of indeterminate colitis in children and adults with IBD - a metaanalysis. , 2009, Journal of Crohn's & colitis.

[41]  A. Schäffer,et al.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.

[42]  M. Daly,et al.  Established genetic risk factors do not distinguish early and later onset Crohn's disease , 2009, Inflammatory bowel diseases.

[43]  M. Novelli,et al.  Inflammatory Bowel Disease in CGD Reproduces the Clinicopathological Features of Crohn's Disease , 2009, The American Journal of Gastroenterology.

[44]  R. Baldassano,et al.  Presentation and Disease Course in Early- Compared to Later-Onset Pediatric Crohn's Disease , 2008, The American Journal of Gastroenterology.

[45]  L. Notarangelo,et al.  Wiskott-Aldrich syndrome. , 2002, Current opinion in hematology.

[46]  William J. Tremaine,et al.  Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940–2000 , 2007, Inflammatory bowel diseases.

[47]  D. Sachar,et al.  Granulomatous Enterocolitis Associated with Hermansky-Pudlak Syndrome , 2006, The American Journal of Gastroenterology.

[48]  A. Auvinen,et al.  Incidence of inflammatory bowel disease in finnish children, 1987–2003 , 2006, Inflammatory bowel diseases.

[49]  J. Hugot,et al.  Ileal Involvement Is Age Dependent in Pediatric Crohn's Disease , 2005, Inflammatory bowel diseases.

[50]  A. Halverson,et al.  Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. , 2005, Gastroenterology.

[51]  A. Lilienfeld,et al.  Trends in incidence rates of ulcerative colitis and Crohn's disease , 1984, Digestive Diseases and Sciences.

[52]  R. Baldassano,et al.  Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. , 2005, The Journal of pediatrics.

[53]  A. Griffiths.  Specificities of inflammatory bowel disease in childhood. , 2004, Best practice & research. Clinical gastroenterology.

[54]  R. Baldassano,et al.  Inflammatory bowel disease in children 5 years of age and younger , 2002, American Journal of Gastroenterology.

[55]  T. Matsumoto,et al.  Inflammatory bowel disease-like colitis in glycogen storage disease type 1b. , 2001, Inflammatory bowel diseases.

[56]  Y. Niv,et al.  Prevalence of ulcerative colitis in the Israeli kibbutz population. , 1991, Journal of clinical gastroenterology.

[57]  H. Adami,et al.  The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. , 1991, Gastroenterology.

[58]  J. Rotter,et al.  Geographic origins of Jewish patients with inflammatory bowel disease. , 1989, Gastroenterology.

[59]  H. Smart,et al.  Crohn's disease in Jewish people--an epidemiological study in south-east Wales. , 1986, Digestion.

[60]  E. Acheson.  The Distribution of Ulcerative Colitis and Regional Enteritis in United States Veterans with Particular Reference to the Jewish Religion , 1960, Gut.